NYSE ARCA | ETF
The fund will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents as well as in securities not included in the index, but which BFA believes will help the fund track the index.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| SUPN | Supernus Pharmaceuticals Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 5.07% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 4.68% |
| XENE | Xenon Pharmaceuticals Inc | Healthcare | Biotechnology | 4.67% |
| ACAD | ACADIA Pharmaceuticals Inc | Healthcare | Biotechnology | 4.45% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 4.40% |
| 326030 | Sk Biopharmaceuticals Co Ltd | Healthcare | Biotechnology | 4.38% |
| KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 4.29% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.11% |
| CERE | Cerevel Therapeutics Holdings Inc | Healthcare | Biotechnology | 4.05% |
| DNLI | Denali Therapeutics Inc | Healthcare | Biotechnology | 4.01% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 3.99% |
| SRRK | Scholar Rock Holding Corp | Healthcare | Biotechnology | 3.96% |
| PTCT | PTC Therapeutics Inc | Healthcare | Biotechnology | 3.70% |
| AXNX | Axonics Modulation Technologies Inc | Healthcare | Medical Devices | 3.69% |
| LBPH | Longboard Pharmaceuticals Inc | Healthcare | Biotechnology | 3.66% |
| ALKS | Alkermes Plc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.57% |
| CPRX | Catalyst Pharmaceuticals Inc | Healthcare | Biotechnology | 3.11% |
| HLUN-B | H Lundbeck A/S | Healthcare | Drug Manufacturers - Specialty & Generic | 3.03% |
| BHVN | Biohaven Pharmaceutical Holding Co Ltd | Healthcare | Biotechnology | 2.97% |
| NEU | Neuren Pharmaceuticals Ltd | Healthcare | Biotechnology | 2.89% |